Moreover, among patients with MSMD due to mutations in IL12Rβ1, ~3 in 4 (77%) present with BCG-associated disease, 4/5 as disseminated and 1/5 as localized complications (319). The gene discussed is IL12RB1; the disease is Mendelian susceptibility to mycobacterial diseases.